Tuberculosis Research and Treatment / 2014 / Article / Tab 2

Research Article

Profile, Outcomes, and Determinants of Unsuccessful Tuberculosis Treatment Outcomes among HIV-Infected Tuberculosis Patients in a Nigerian State

Table 2

Predictors of unsuccessful tuberculosis treatment outcomes among 233 rural TB/HIV patients in Ebonyi State, Nigeria, 2011-2012.

CharacteristicsSuccessful outcome
(%)
Unsuccessful outcome
(%)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Adjusted value

Age (years)
 ≤40106 (60.6)69 (39.4)1.07 (0.6–2.0)1.06 (0.5–2.1)0.86
 >4036 (62.1)22 (37.9)11
Gender
 Female65 (58.0)47 (42.0)1.26 (0.8–2.1)1.26 (0.7–2.3)0.43
 Male77 (63.6)44 (36.8)11
Facility
 Public23 (38.3)37 (61.7)3.6 (1.9–6.5)3.8 (1.9–7.7)<0.001
 Private119 (68.8)54 (31.2)11
Treatment category
 New132 (60.8)85 (39.2)1.07 (0.4–3.1)1.06 (0.4–3.2)0.92
 Previously treated10 (62.5)6 (37.5)11
Type of TB
 Pulmonary139 (61.8)86 (38.2)11
 Extrapulmonary3 (37.5)5 (62.5)2.7 (0.6–11.6)1.2 (0.3–6.0)0.80
Anti-TB regimen
 Regimen 172 (55.8)57 (44.2)1.6 (0.9–2.8)1.7 (0.9–3.2)0.096
 Regimen 270 (67.3)34 (32.7)11
Received ART
 Yes47 (58.8)33 (41.2)1.2 (0.7–2.0)1.2 (0.5–2.5)0.71
 No95 (62.1)58 (37.9)11
Received CPT
 Yes79 (60.3)52 (39.7)1.06 (0.6–1.8)1.0 (0.5–2.0)0.98
 No63 (61.8)39 (38.2)11

Regimen 1: 2RHZE/6EH; regimen 2: 2RHZE/4RH (R: rifampicin, H: isoniazid, Z: pyrazinamide, and E: ethambutol); OR: odds ratio; ART: antiretroviral therapy; TB: tuberculosis; HIV: human immunodeficiency virus; CPT: cotrimoxazole preventive therapy.